P1058a (DAIDS ID 10809): Intensive Pharmacokinetic Studies of New Classes of Antiretroviral Drug Combinations in Children, Adolescents, and Young Adults

Study Status Study Restriction

Participants Off Study and Primary Analysis Completed

United States

What is P1058a?

P1058a is a pharmacokinetic study of new classes of antiretroviral (ARV) drug combinations in children, adolescents, and young adults (6-23 years of age).  The study is designed to evaluate the 12- and/or 24-hour pharmacokinetics of up to 17 ARV drug combinations in approximately 200 participants in the US (15-40 participants per drug combination).

Study documents:

Sites where the study is implemented:

CRS ID Site Name City Country


Rush University Cook County Hospital Chicago NICHD CRS


United States of America

Study contacts:

Clinical Trials Specialist: Katherine Calabrese

Clinical Trials Specialist: Anne Coletti

CTS: Anne Coletti


Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.